Francis Chou - Chou Associates Management 13F Activity & Position Changes (Q4 2019)

As of Dec 31, 2019, the Chou Associates Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2019, the filing reported:

New Buys - None reported

Increases - None reported

Reductions - Bank of America Corporation, Bausch Health Companies Inc., DaVita Inc., Wells Fargo & Company

Complete Exits - Teva Pharmaceutical Industries

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2019	BAC Bank of America Corporation	Bank of America Corporation	Sell	-65,000	-69.6%	$999.00	28,376
Q4 2019	BHC Bausch Health Companies Inc.	Bausch Health Companies Inc.	Sell	-30,000	-1.8%	$48.44K	1,618,992
Q4 2019	DVA DaVita Inc.	DaVita Inc.	Sell	-20,000	-16.6%	$7.56K	100,743
Q4 2019	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Sell - Position Exit	-15,000	-100.0%	$0.00	-
Q4 2019	WFC Wells Fargo & Company	Wells Fargo & Company	Sell	-130,000	-38.3%	$11.27K	209,542